Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 May 2025 | Story André Damons | Photo Supplied
Prof Wynand Goosen
Prof Wynand Goosen, Professor and Lead for One Health in the Department of Microbiology and Biochemistry at the University of the Free State was nominated in the TW Kambule-NSTF Award: Researcher category of the 2024/25 NSTF-South32 Awards.

Being nominated for a ‘Science Oscar’ is exciting and validates nominees’ efforts, particularly in a field as challenging and essential as infectious diseases, for which they are recognised at the highest level. 

This is according to Prof Wynand Goosen, Professor and Lead for One Health in the Department of Microbiology and Biochemistry at the University of the Free State (UFS). He was nominated in the TW Kambule-NSTF Award: Researcher category of the 2024/25 NSTF-South32 Awards for his landmark discovery of Mycobacterium bovis infection in humans in South Africa – the first confirmed cases in the country. 

Prof Goosen, who previously won the NSTF-South32 Emerging Researcher Award, says the nomination is a powerful affirmation of the impact that focused, interdisciplinary research can have. It reflects not only his personal commitment but also the dedication of a talented and hard-working team. “I am honoured and humbled to be nominated. It is also a testament to the support and vision of UFS, particularly as we position ourselves as leaders in One Health research in South Africa,” he says. 

 

Focus of research 

He was nominated by Prof Vasu Reddy, UFS Deputy Vice-Chancellor: Research and Internationalisation, and Prof Paul Oberholster, Dean for the Faculty of Natural and Agricultural Sciences (NAS) at the UFS, and Prof Nico Gey van Pittius and Prof Elmi Muller from Stellenbosch University (US). The NSTF Awards, known as the ‘Science Oscars’of SA, honour, reward, celebrate, profile and promote outstanding contributions to science, engineering and technology (SET) and innovation in South Africa.

“The nomination,” Prof Goosen continues, “recognises our work in the field of zoonotic tuberculosis (TB) and other emerging infectious diseases at the human-animal-environment interface. Our research focuses on the molecular detection and characterisation of pathogenic mycobacteria in wildlife, livestock, and human populations, with the aim of informing better surveillance, diagnostics, and control strategies — particularly in high-risk ecosystems. This includes novel applications in wildlife TB surveillance and understanding the transmission dynamics between animals and people.”

 

Establishing a Kovsie One Health Research Unit

This research is critically important as South Africa continues to face a high burden of tuberculosis, including zoonotic TB, which often goes under-detected in rural and wildlife-rich areas. Understanding how these pathogens circulate between humans, animals, and the environment, explains Prof Goosen, is essential for effective disease control and to mitigate future pandemics. This work directly supports national health priorities, informs policy, and contributes to global strategies for One Health.

Prof Goosen and the team are in the process of laying the groundwork for the establishment of a Kovsie One Health Research Unit, which will serve as a collaborative platform for research spanning human, animal, and environmental health. One of their key projects involves expanding TB and AMR surveillance in wildlife-livestock-human interfaces, using cutting-edge diagnostics and genomic tools. They are also initiating partnerships with industry and international institutions to address emerging zoonoses and environmental pathogens in a transdisciplinary manner.

News Archive

Mekondjo! National exhibition to reveal the courage, determination, repression and torture of PLAN
2014-05-21

 
Angelina Angula ex PLAN soldier injured during the 1978 Cassinga attack - photo by John Liebenberg.

A pioneering exhibition by John Liebenberg and Christo Doherty is about to open on the Bloemfontein Campus. ‘Mekondjo! born in the struggle for Namibia’ gives South Africans their first insight into the lives of the men and women who fought against the SADF in the bush of Northern Namibia and Angola from 1966 – 1989.

This public exhibition presents eleven portraits of People’s Liberation Army veterans in the process of speaking about and coming to terms with their very different experiences in the Namibian War of Liberation.

When the People’s Liberation Army (PLAN) returned to Namibia after the UN-supervised elections of 1989, it had been fighting against South African rule for 23 years. Formed in 1966 as the armed wing of the South West African Peoples’ Organisation, PLAN had developed from a handful of poorly armed guerrillas to a sophisticated mechanised force. These soldiers fought alongside Angolan, Russian and Cuban soldiers against the SADF and UNITA. Since SWAPO’s election victory, the new government has mythologised the heroism of the armed struggle. The stories of the individual PLAN fighters’ experiences are only now being articulated, though.

Their stories are of great courage and determination against often impossible odds; but also of repression, torture, and disastrous decisions by the PLAN leadership.

The exhibition will be on display from Thursday 22 May to Friday 23 May for the duration of the Silence after Violence conference. The conference is hosted by the UFS Institute for Reconciliation and Social Justice and the Center for Holocaust Studies at the University of Vermont.

Date: Thursday 22 May and Friday 23 May 2014
Place: Centenary Complex, Reitz Hall, Bloemfontein Campus
Exhibition Introduction: Thursday 22 May, 14:00 – 15:30
Other viewing times: intermissions during the Silence after Violence programme

The public is welcome to attend.

* Spotlight photo: PLAN commissioner Nkrumah Mushelenga, Windhoek 2013 – photo by John Liebenberg

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept